Listed

Rigel Pharmaceuticals Inc: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 5, 2021 and accepted by EDGAR at May 5, 2021, 16:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$81.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-01-01 to 2021-03-31$316.0kus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2021-01-01 to 2021-03-31$22.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-01-01 to 2021-03-31$41.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-01-01 to 2021-03-31$485.0kus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31$1.8mus-gaap:IncomeTaxExpenseBenefit
Diluted EPS3 months2021-01-01 to 2021-03-31$0.22us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-01-01 to 2021-03-31$0.23us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-01-01 to 2021-03-31176,069,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-01-01 to 2021-03-31−$20.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$71.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-03-31$20.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$196.8mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$216.0mus-gaap:Assets
Current liabilitiesAt period end2021-03-31$52.0mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2021-03-31$20.0mus-gaap:LongTermDebt
Shareholders' equityAt period end2021-03-31$78.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-21-005903. Last ingested by Listed: Nov 14, 2026, 23:09 ET. Listed shows no prices and gives no investment advice.